Livingstone’s Industrial sector team has advised the shareholders of HEL Limited on an investment by Connection Capital.
HEL is a market leader in the design and production of advanced research and pre-pilot chemical reactors and related instruments. The business has been highly successful in selling its automated laboratory instruments to leading global pharmaceutical and chemical companies as well as universities and research institutions across Europe, North America and Asia. HEL’s instruments help manufacturers to develop their new products in the safest and most cost-effective manner.
The transaction sees private equity investor Connection Capital take a minority investment in HEL and the addition of experienced Chairman Andrew Dixey and a new Finance Director to the existing senior team led by founder Dr. Jasbir Singh.
Graham Carberry, Partner at Livingstone commented: “HEL is an outstanding and highly innovative business and we’re delighted to have advised the shareholders on a transaction that positions HEL for sustained growth.”
Tom Smith, Associate Director at Livingstone adds: “HEL is a fantastic business, ideally positioned to benefit from both the strong global growth in laboratory automation and the increasing importance of safety and optimised production across a range of applications from biopharma to battery testing. We believe Connection have backed a special business.”
Dr. Jasbir Singh, Founder and majority shareholder of HEL added: “We chose to work with Livingstone because of their significant track record of advising on successful lab instrumentation transactions. Not only their understanding of our market, but their passion for our business and drive to get us the best result possible was outstanding from start to finish.”
This transaction within advanced laboratory instrumentation follows quickly on from the sale of x-ray detectors manufacturer RaySpec to Polatechno of Japan in December 2017 and several other recent transactions in the space including the sales of Nu Instruments to AMETEK and Specac to Foresight.
“We chose to work with Livingstone because of their significant track record of advising on successful lab instrumentation transactions. Not only their understanding of our market, but their passion for our business and drive to get us the best result possible was outstanding from start to finish.”